Caristo's CaRi-Heart® FAI-Score™ Demonstrates Superior Prognostic Capability in Landmark Study of 19,110 Patients Published in JAMA Cardiology

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

CARISTO-DIAGNOSTICS

More Like This

PR Newswire associated0

New Data at ESC Congress 2026 Validate Caristo's FAI-Score™ Biomarker and Highlight Potential Non-Contrast Cardiac CT Opportunity

PR Newswire associated0

European Society of Cardiology (ESC) Congress 2025 Late Breaking Results Confirm Caristo FAI-Score™ Technology's Superior and Complementary Predictive Value for Cardiac Death Beyond hsCRP

PR Newswire associated0

Caristo to Unveil New Clinical and Research Results at SCCT 2025

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

PR Newswire associated0

Caristo Diagnostics' CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA

PR Newswire associated0

The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation At Least 10 Years in Advance

PR Newswire associated0

Caristo's Technology to be Featured in Non-Contrast CT and Late-Breaking Stroke Prediction Data at ESC 2026

PR Newswire associated0

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI